FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

391821005: Benserazide (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2757565012 Benserazide (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2771267013 Benserazide en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Benserazide (substance) Is a Antiparkinsonian agent (substance) false Inferred relationship Some
Benserazide (substance) Is a Substance with dihydroxyphenylalanine decarboxylase inhibitor mechanism of action (substance) true Inferred relationship Some
Benserazide (substance) Is a Hydrazine false Inferred relationship Some
Benserazide (substance) Has disposition (attribute) Dihydroxyphenylalanine decarboxylase inhibitor (disposition) true Inferred relationship Some
Benserazide (substance) Is a Chemical categorized functionally false Inferred relationship Some
Benserazide (substance) Is a Hydrazine and/or hydrazine derivative true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Benserazide hydrochloride Is a False Benserazide (substance) Inferred relationship Some
Benserazide + levodopa adverse reaction Causative agent False Benserazide (substance) Inferred relationship Some 2
Allergy to benserazide and levodopa Causative agent False Benserazide (substance) Inferred relationship Some
Product containing precisely benserazide 12.5 milligram and levodopa 50 milligram/1 each conventional release oral capsule (clinical drug) Has active ingredient False Benserazide (substance) Inferred relationship Some
Benserazide 25 mg and levodopa 100 mg oral capsule Has active ingredient False Benserazide (substance) Inferred relationship Some
Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) Has active ingredient False Benserazide (substance) Inferred relationship Some
Co-beneldopa 12.5mg/50mg dispersible tablet Has active ingredient False Benserazide (substance) Inferred relationship Some
Co-beneldopa 25mg/100mg m/r capsule Has active ingredient False Benserazide (substance) Inferred relationship Some
Co-beneldopa 25mg/100mg dispersible tablet Has active ingredient False Benserazide (substance) Inferred relationship Some
Product containing benserazide (medicinal product) Has active ingredient True Benserazide (substance) Inferred relationship Some 1
Product containing benserazide and levodopa (medicinal product) Has active ingredient True Benserazide (substance) Inferred relationship Some 2
Co-beneldopa 25mg/100mg prolonged-release oral capsule Has active ingredient False Benserazide (substance) Inferred relationship Some
Allergy to benserazide and levodopa Causative agent False Benserazide (substance) Inferred relationship Some 1
Benserazide hydrochloride Is modification of (attribute) True Benserazide (substance) Inferred relationship Some
Benserazide only product Has active ingredient True Benserazide (substance) Inferred relationship Some 1
Product containing only benserazide and levodopa (medicinal product) Has active ingredient True Benserazide (substance) Inferred relationship Some 2
Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) Has basis of strength substance (attribute) True Benserazide (substance) Inferred relationship Some 2
Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) Has precise active ingredient True Benserazide (substance) Inferred relationship Some 2
Benserazide 12.5 mg and levodopa 50 mg oral tablet Has precise active ingredient True Benserazide (substance) Inferred relationship Some 2
Benserazide 12.5 mg and levodopa 50 mg oral tablet Has basis of strength substance (attribute) True Benserazide (substance) Inferred relationship Some 2
Product containing benserazide and levodopa in oral dose form (medicinal product form) Has active ingredient True Benserazide (substance) Inferred relationship Some 2
Benserazide and levodopa only product in oral dose form Has active ingredient True Benserazide (substance) Inferred relationship Some 2
Product containing precisely benserazide 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Benserazide (substance) Inferred relationship Some 2
Product containing precisely benserazide 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Benserazide (substance) Inferred relationship Some 2
Product containing precisely benserazide 12.5 milligram and levodopa 50 milligram/1 each conventional release oral capsule (clinical drug) Has basis of strength substance (attribute) True Benserazide (substance) Inferred relationship Some 2
Product containing precisely benserazide 12.5 milligram and levodopa 50 milligram/1 each conventional release oral capsule (clinical drug) Has precise active ingredient True Benserazide (substance) Inferred relationship Some 2
Benserazide 25 mg and levodopa 100 mg oral capsule Has basis of strength substance (attribute) True Benserazide (substance) Inferred relationship Some 2
Benserazide 25 mg and levodopa 100 mg oral capsule Has precise active ingredient True Benserazide (substance) Inferred relationship Some 2

Reference Sets

GB English

US English

Back to Start